8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,703) Views
Editor in Chief Professor Garry Walsh
1178-203X
Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence
David RP Guay
Therapeutics and Clinical Risk Management 2005, 1:157-166
20 January 2005
Clinical implications of changes in hepatic drug metabolism in older people
Sarah N Hilmer, Gillian M Shenfield, David G Le Couteur
Therapeutics and Clinical Risk Management 2005, 1:151-156
20 January 2005
Renal replacement therapy in the intensive care unit
Neesh Pannu, RT Noel Gibney
Therapeutics and Clinical Risk Management 2005, 1:141-150
20 January 2005
The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?
Deanna L McDanel, Barbara A Muller
Therapeutics and Clinical Risk Management 2005, 1:125-140
20 January 2005
Risk factors of allergic rhinitis: genetic or environmental?
De-Yun Wang
Therapeutics and Clinical Risk Management 2005, 1:115-123
20 January 2005
Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy
Charity D Scripture, William D Figg, Alex Sparreboom
Therapeutics and Clinical Risk Management 2005, 1:107-114
20 January 2005
A review of studies of adherence with antihypertensive drugs using prescription databases
Nicola Fitz-Simon, Kathleen Bennett, John Feely
Therapeutics and Clinical Risk Management 2005, 1:93-106
20 January 2005
The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma
Graeme P Currie, Tom C Fardon, Daniel KC Lee
Therapeutics and Clinical Risk Management 2005, 1:83-92
20 January 2005
The controversy surrounding OxyContin abuse: issues and solutions
Sujata S Jayawant, Rajesh Balkrishnan
Therapeutics and Clinical Risk Management 2005, 1:77-82
19 March 2005
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
